<DOC>
	<DOC>NCT01038297</DOC>
	<brief_summary>The study will investigate the ability of different dose levels and regimens of EXC 001 to improve the appearance of scars in subjects undergoing an elective abdominoplasty. The study will also evaluate the safety and tolerability of EXC 001.</brief_summary>
	<brief_title>Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty</brief_title>
	<detailed_description />
	<criteria>Subjects must have sufficient excess abdominal tissue to qualify for a standard elective abdominoplasty Subject has chosen to have an elective abdominoplasty Medically healthy with normal screening results Subjects must not be pregnant or lactating Subjects with existing scars or significant striae on the abdominal pannus Females who are currently pregnant or pregnant during the 12 months prior to inclusion in the study, or lactating Participation in another clinical trial within 30 days prior to the start of the study Any other condition or prior therapy, which, in the opinion of the PI, would make the subject unsuitable for this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Scarring</keyword>
</DOC>